Advertisement

Topics

Search Results for "Reminder Sample Letter Prostate Cancer"

16:28 EDT 27th March 2017 | BioPortfolio

Matching Channels

Prostate Cancer in Men

Prostate cancer is the most common cancer in men in the UK; affecting 250,000 men. Risk factors for prostate cancer include age (average age at diagnosis is 70), a family history and a Caribbean or ...

Prostate Cancer Cellular Vaccine rDNA

Prostate specific membrane antigen PSMA

Prostate-specific membrane antigen (PSMA) is a transmembrane protein commonly found on the surface of late-stage and metastatic prostate cancer and a well-known imaging biomarker for staging and monit...

Abiraterone Acetate - Zytiga

On April 28, 2011, the US Food and Drug Administration (FDA) approved Zytiga (abiraterone acetate), for use in combination with prednisone for the second-line treatment of castration-resistant prost...

Prostate Mab

Matching News

PSA: The Prostate Cancer Screening Test

Prostate cancer is the second most common cancer in American men, following skin cancer. One in every seven men will be diagnosed with this form of cancer in his lifetime; with the average age of diag...

New radiotracer could make diagnosing prostate cancer faster and easier

A new radiotracer has been developed to diagnose prostate cancer. Prostate cancer is the fifth leading cause of death worldwide and is especially difficult to diagnose. While prostate cancer is relati...

Medical News Today: How to Improve Your Sex Life After Prostate Cancer

What is the prostate gland and how can prostate cancer affect sexual behavior? Learn how to manage your sex life after prostate cancer and its treatment.

Precision Medicine Approach Could Revive Prostate Cancer Test

A new study led by researchers at UC San Francisco and Kaiser Permanente has identified genetic predictors of normal prostate-specific antigen (PSA) levels in healthy men, which could be used to impro...

Research helps explain why androgen-deprivation therapy doesn't work for many prostate cancers

Metastatic prostate cancer, or prostate cancer that has spread to other organs, is incurable. In new research published in the journal Science, Roswell Park Cancer Institute scientists have identified...

Prostate Cancer Outlook for 2017: The Search for Actionable Targets Continues

Six therapies have demonstrated improved survival in metastatic castration-resistant prostate cancer, yet there is insufficient data regarding combination and sequencing of these agents, and predictin...

Do second opinions matter in prostate cancer care?

(Wiley) A new analysis indicates that many men with prostate cancer obtain second opinions from urologists before starting treatment, but surprisingly, second opinions are not associated with changes ...

SBRT in prostate cancer

Dr Greco speaks with ecancertv at the IX French-Brazilian Oncology CongressĀ about radiotherapy for prostate cancer. He describes the history of modelling radio-modalities in treating prostate cancer...

Matching PubMed Articles

Gene expression profile of FVII and AR in primary prostate cancer.

The ectopic expression of coagulation Factor VII has been shown in various cancers. Recently, F7 gene has been identified as a direct target of the androgen receptor in breast cancer. In this study, w...

Intraductal Carcinoma of the Prostate on Diagnostic Needle Biopsy Predicts Prostate Cancer Mortality: A Population-Based Study.

Intraductal carcinoma of the prostate (IDC-P) is a distinct histopathologic feature associated with high-grade, advanced prostate cancer. Although studies have shown that IDC-P is a predictor of progr...

Digoxin and prostate cancer survival in the Finnish Randomized Study of Screening for Prostate Cancer.

Protective effects have been suggested for digoxin against prostate cancer risk. However, few studies have evaluated the possible effects on prostate cancer-specific survival. We studied the associati...

Patients' perceptions of the negative effects following different prostate cancer treatments and the impact on psychological well-being: a nationwide survey.

Although the prognosis of localised prostate cancer is good, the negative effects of prostate cancer treatment often impair patient quality of life. A growing number of men experience these negative e...

Prostate cancer.

Prostate cancer is the most frequent tumor found in men worldwide and in Mexico in particular. Age and family history are the main risk factors. The diagnosis is made by prostate biopsy in patients wi...

Search Whole site using Google

Loading
Quick Search
Advertisement
 
Advertisement Advertisement